Geoff Carr Fellowship

Lupus Ontario Geoff Carr Fellowship

Donate Today

Applications for the 2025-26 year are now closed.

35+ Fellows Trained

The annual Geoff Carr Fellowship has trained over 35 fellows in best practices in diagnosing and treating lupus. Each fellow has participated in critical lupus research.

Improving Quality of Life

It currently takes an average of 6 years for a patient to get a proper diagnosis of lupus.  The education received by these fellows is changing the quality of life and outcomes for many lupus patients.  The Fellowship is open to applicants from around the world with preference given to Canadians.   

Geoff Carr
2024-2025
Toronto Western Hospital
Dr.Justin Smith
2023-2024
Toronto Western Hospital
Dr. Teresa Semalulu

Exploring racial disparities in disease-related activity and damage in SLE.

2022 - 2023
SickKids Hospital
Dr. Stephanie Wong

Therapeutic drug monitoring of HCQ is feasible in the cSLE population, allowing for individualized HCQ treatment with optimal efficacy and prevention of long- term toxicity.

2021 - 2022
SickKids Hospital
Dr. Tala El Tal

Research focuses in neuropsychiatric (NPSLE), specifically examining the longitudinal prevalence of cognitive impairment and relationship to disease and health-related quality of life in cSLE.

2020 - 2021
Toronto Western Hospital
Dr. Ambika Gupta

Determination of the clinical subtypes of cognitive impairment in SLE patients to facilitate precision health care and better outcomes.

2019 - 2020
Toronto Western Hospital
Dr. Laura Whittal Garcia

The potential role of serum HMGB1 from NETs as a biomarker to predict residual renal inflammation and subsequent flares in patients with lupus nephritis.

2018 -2019
SickKids Hospital
Dr. Anita Dhanrajani

The potential role of serum HMGB1 from NETs as a biomarker to predict residual renal inflammation and subsequent flares in patients with lupus nephritis.

2017-2018
Toronto Western Hospital
Dr. Konstantinos Tselios

Prolonged antimalarial treatment may increase the risk for subclinical heart damage in systemic lupus erythematosus.

2016-2017
SickKids Hospital
Dr. Julie Couture

Depression in paediatric SLE patients.

2015 - 2016
Toronto Western Hospital
Dr. Jorge Medina Rosas

Prolonged antimalarial treatment may increase the risk for subclinical heart damage in systemic lupus erythematosus.

2014 - 2015
Toronto Western Hospital
Dr. Konstantinos Tselios

The management of Arterial Hypertension and Hypercholesterolemia in patients with SLE. Are the current treatment guidelines adequate for lupus patients?

2013 - 2014
McMaster University
Dr. Kim Legault

Pathophysiology of cognitive dysfunction in patients with antiphospholipid antibodies and lupus.

2012 - 2013
Toronto Western Hospital
Dr. Barry Sheane

Cardio vascular risks in patients with SLE.

2011 - 2012
Toronto Western Hospital
Dr. Amanda Steiman

Predicting flares in patients who are serologically active and and clinically quiescent.

2010 - 2011
Dr. Zahi Touma

SRI-50 Index which is used to measure disease activity.

2009 - 2010
McMaster University
Dr. Derek Haaland

Lupus Nephritis.

2008 -2009
SickKids Hospital
Dr. Satish Kumar

Long term outcome of children with SLE with emphasis on the Central Nervous System 

2008 -2009
Toronto Western Hospital
Dr. Zahi Touma

Outcome measures used in clinical trials in SLE in order to find an optimal measure.

2007-2008
Toronto Western Hospital
Dr. Desiree Tulloch-Reid

Lupus Nephritis.

2006-2007
Dr. Mandana Nikpour

Atherscerlosis in SLE

2005-2006
Toronto Western Hospital
Dr. Zhaleh Shariati

Definition of thrombitis risk associated with anticardiolipin antibofy in SLE

2004-2005
Toronto Western Hospital
Dr. Mandana Nikpour

Vascular disease in systemic Lupus Erythematosus

2003-2004
SickKids Hospital
Dr. Susanne Benseler

Methods to improve paediatric Lupus treatment.

2002-2003
Toronto Lupus Clinic
Dr. Adrienne Williamson
2001-2002
Dr. Marie Feletar

Impact of the updated 1997 revised criteria for classification of SLE, Prolonged remission in SLE

2000-2001
Toronto Lupus Clinic
Dr. Dana Jerome

The effective of menopause on disease activity in SLE

1999-2000
Dr. Anna Jaroszynska

Bone mineral density in premenopausal females with SLE

1998-1999
Toronto Lupus Clinic
Dr. Santiago Aguero
1997-1998
SickKids Hospital
Dr. Stefan Hagelberg

Pathogenic mechanisms in lupus patients with CNS involvement

1996-1997
University of Toronto
Dr. Ian Bruce

Assess the prevalence of ischemic heart disease in patients with SLE, current management of risk factors for coronary artery disease

1995-1996
McMaster University
Dr. Sergio Toloza
1994-1995
The Wellesley Hospital / University of Toronto
Dr. Vandana Chaudry

Osteonecrosis in SLE

1993-1994
The Wellesley Hospital / University of Toronto
Dr. Mahmood Abu-Shakra
  • Anticardiolipin Antibodies in SLE: Clinical and Laboratory Correlations
  • The Significance of Anticardiolipin Antibodies in patients with Lupus Nephritis
1992-1993
The Wellesley Hospital / University of Toronto
Dr. Julie Kovacs

Single Photon Emission Computerized Tomography (SPECT) in Neuropsychiatric SLE

1991-1992
The Wellesley Hospital / University of Toronto
Dr. Rachel Pauzner
  • Prolactin in SLE
  • Anti-neutrophil Cytoplasmic Antibodies (ANCA) in SLE
  • Evaluation of predictive factors for neurocognitive dysfunction in patients with SLE
1990-1991
The Wellesley Hospital / University of Toronto
Dr. Barbara Walz-Leblanc

Serologically Active Clinically Quiescent Systemic Lupus Erythematosus (SLE) - Predictors of Clinical Flares